Estimation of the Tissue and Serum Levels of Interleukin (IL) -35 in Mycosis Fungoides: a Case Control Study
- Conditions
- Mycosis Fungoides
- Registration Number
- NCT05855460
- Lead Sponsor
- Cairo University
- Brief Summary
Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35.
- Detailed Description
Tissue and serum samples from 20 MF patients and 20 normal healthy controls will be subjected for biochemical assessments by ELISA (Enzyme- linked immune-sorbent assay) for assessing the level of IL35
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 20
- Patients with mycosis fungoides. Both genders. Age group ≥ 18 years old.
- Patients with any other skin diseases. Patients who received treatments for mycosis fungoides in the past three months.
Subjects with history of solid or hematological malignancy as leukemia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare tissue and serum levels of interleukin 35 (IL -35) in mycosis fungoides patients and normal controls. 1 year To assess and compare tissue and serum levels of interleukin 35 (IL -35) in mycosis fungoides patients and normal controls.
- Secondary Outcome Measures
Name Time Method Correlating tissue and serum levels of IL-35 in mycosis fungoides patients with patients age, sex, duration, extent and stage of the disease. L 1 year Correlating tissue and serum levels of IL-35 in mycosis fungoides patients with patients age, sex, duration, extent and stage of the disease.
Trial Locations
- Locations (1)
Cairo University
🇪🇬Giza, Egypt
Cairo University🇪🇬Giza, EgyptSally DossContact01223283288Sallydoss@hotmail.comYasmine Obaid, ResidentSub InvestigatorZeinab Nour, MDSub Investigator